Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB

被引:0
|
作者
Negoro, Kenji
Yamano, Yukio
Fushimi, Kazuaki
Saito, Kengo
Nakatani, Ken
Shiiba, Masashi
Yokoe, Hidetaka
Bukawa, Hiroki
Uzawa, Katsuhiro
Wada, Takeshi
Tanzawa, Hideki
Fujita, Shigeyuki
机构
[1] Chiba Univ, Dept Biol Mol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
[2] Chiba Univ, Ctr Excellence Program 21st Century, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan
[3] Wakayama Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, Wakayama, Japan
[4] Chiba Univ Hosp, Div Oral & Maxillofcial Surg, Chiba, Japan
关键词
cisplatin; drug resistance; MTT assay; microarray; pathway analysis; COMBINATION CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; COLORIMETRIC ASSAY; CANCER-PATIENTS; OVARIAN-CANCER; LUNG-CANCER; HEAD; NECK; GENE; CHEMOSENSITIVITY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the mechanism of the resistance to cisplatin (CDDP), we established the CDDP-resistant cell line, KB-R, from CDDP-sensitive oral carcinoma cell line, KB. The 3-(3, 4-dimethyl-thiazol-2-yl) 2, 5-diphenyltetrazolium bromide (MTT) assay indicated that KB-R is 5.5-fold more resistant to CDDP than KB. Microarray analysis indicated that the expression levels of 1,718 genes were elevated at least fivefold or more in KB-R, compared with KB. The expression status of ATP binding cassette (ABC) transporter genes, which belong to multi-drug resistance genes, was confirmed by semi-quantitative reverse transcriptase-polymerase chain reaction and real-time PCR. MRP1 and MRP2 were up-regulated, whereas MDR1 was down-regulated. Pathway and ontology analysis using the Ingenuity Pathway Analysis tool indicated three highly significant genetic networks including 105 of the 1,718 overexpressed genes and one network including 35 'cell-to-cell signaling and interaction' related genes. Our results suggested that these cell lines, KB and KB-R, may be useful for searching the candidate genes responsible for CDDP-resistance and for further study to understand the mechanism of CDDP-resistance.
引用
收藏
页码:1325 / 1332
页数:8
相关论文
共 50 条
  • [1] Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R
    Nakamura, M
    Nakatani, K
    Uzawa, K
    Ono, K
    Uesugi, H
    Ogawara, K
    Shiiba, M
    Bukawa, H
    Yokoe, H
    Wada, T
    Fujita, S
    Tanzawa, H
    ONCOLOGY REPORTS, 2005, 14 (05) : 1281 - 1286
  • [2] Establishment and gene analysis, of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinoma
    Nakatani, K
    Nakamura, M
    Uzawa, K
    Wada, T
    Seki, N
    Tanzawa, H
    Fujita, S
    ONCOLOGY REPORTS, 2005, 13 (04) : 709 - 714
  • [3] Establishment and characterization of a cisplatin-resistant human neuroblastoma cell line
    Yasuno, T
    Matsumura, T
    Shikata, T
    Inazawa, J
    Sakabe, T
    Tsuchida, S
    Takahata, T
    Miyairi, S
    Naganuma, A
    Sawada, T
    ANTICANCER RESEARCH, 1999, 19 (5B) : 4049 - 4057
  • [4] Establishment and characterization of a cisplatin-resistant human osteosarcoma cell line
    Han, Tao
    Zhu, Xiaoming
    Wang, Julei
    Zhao, Haien
    Ma, Qiong
    Zhao, Jian
    Qiu, Xiuchun
    Fan, Qingyu
    ONCOLOGY REPORTS, 2014, 32 (03) : 1133 - 1139
  • [5] Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line
    Asada, N
    Tsuchiya, H
    Ueda, Y
    Tomita, K
    ANTICANCER RESEARCH, 1998, 18 (3A) : 1765 - 1768
  • [6] Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line
    Negoro, Kenji
    Yamano, Yukio
    Nakashima, Dai
    Saito, Kengo
    Nakatani, Ken
    Shiiba, Masashi
    Bukawa, Hiroki
    Yokoe, Hidetaka
    Uzawa, Katsuhiro
    Wada, Takeshi
    Tanzawa, Hideki
    Fujita, Shigeyuki
    ONCOLOGY REPORTS, 2009, 21 (02) : 443 - 449
  • [7] Establishment and characterization of a cisplatin-resistant cell line (IGSK-1) from a poorly differentiated gastric adenocarcinoma
    Ohi, Satoshi
    Takahashi, Naoto
    Ninomiya, Kouzou
    Nakajima, Masako
    Hashimoto, Hisashi
    Tachibana, Toshiaki
    Yanaga, Katsuhiko
    Ishikawa, Hiroshi
    HUMAN CELL, 2007, 20 (01) : 15 - 22
  • [8] Establishment and characterization of a cisplatin-resistant cell line (IGSK-1) from a poorly differentiated gastric adenocarcinoma
    Satoshi Ohi
    Naoto Takahashi
    Kouzou Ninomiya
    Masako Nakajima
    Hisashi Hashimoto
    Toshiaki Tachibana
    Katsuhiko Yanaga
    Hiroshi Ishikawa
    Human Cell, 2007, 20 : 15 - 22
  • [9] HYPERTHERMIC POTENTIATION OF CISPLATIN TOXICITY IN A HUMAN SMALL-CELL LUNG-CARCINOMA CELL-LINE AND A CISPLATIN-RESISTANT SUBLINE
    HETTINGA, JVE
    LEMSTRA, W
    MEIJER, C
    MULDER, NH
    KONINGS, AWT
    DEVRIES, EGE
    KAMPINGA, HH
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1994, 10 (06) : 795 - 805
  • [10] Analysis of ceRNA network of differentially expressed genes in FaDu cell line and a cisplatin-resistant line derived from it
    Zhang, Gehou
    Tan, Guolin
    Li, Tieqi
    Ai, Jingang
    Song, Yexun
    Zhou, Zheng
    Xiao, Jian
    Li, Wei
    PEERJ, 2021, 9